Page last updated: 2024-09-05

melagatran and Vascular Diseases

melagatran has been researched along with Vascular Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eichner, G; Eickhoff, M; Elg, M; Fassbender, M; Leithäuser, B; Matthias, FR	1

Other Studies

1 other study(ies) available for melagatran and Vascular Diseases

Article	Year
The direct thrombin inhibitor melagatran counteracts endotoxin-induced endothelial leukocyte adherence and microvascular leakage in the rat mesentery. Rationale for the treatment of inflammatory disorders beyond sepsis? Clinical hemorheology and microcirculation, 2007, Volume: 36, Issue:4 Topics: Animals; Antithrombin III; Azetidines; Benzylamines; Capillary Permeability; Cell Adhesion; Endothelium, Vascular; Inflammation; Interleukin-6; Leukocyte Adherence Inhibition Test; Leukocytes; Lipopolysaccharides; Male; Mesentery; Microcirculation; Peptide Hydrolases; Rats; Rats, Sprague-Dawley; Vascular Diseases	2007

Article

Year

The direct thrombin inhibitor melagatran counteracts endotoxin-induced endothelial leukocyte adherence and microvascular leakage in the rat mesentery. Rationale for the treatment of inflammatory disorders beyond sepsis?

Clinical hemorheology and microcirculation, 2007, Volume: 36, Issue:4

Topics: Animals; Antithrombin III; Azetidines; Benzylamines; Capillary Permeability; Cell Adhesion; Endothelium, Vascular; Inflammation; Interleukin-6; Leukocyte Adherence Inhibition Test; Leukocytes; Lipopolysaccharides; Male; Mesentery; Microcirculation; Peptide Hydrolases; Rats; Rats, Sprague-Dawley; Vascular Diseases

2007